Myeloid‐derived suppressor cell heterogeneity in human cancers

S Solito, I Marigo, L Pinton, V Damuzzo… - Annals of the New …, 2014 - Wiley Online Library
The dynamic interplay between cancer and host immune system often affects the process of
myelopoiesis. As a consequence, tumor‐derived factors sustain the accumulation and …

Complexity and challenges in defining myeloid‐derived suppressor cells

V Damuzzo, L Pinton, G Desantis… - Cytometry Part B …, 2015 - Wiley Online Library
Study of myeloid cells endowed with suppressive activity is an active field of research which
has particular importance in cancer, in view of the negative regulatory capacity of these cells …

[HTML][HTML] Myeloid cells as clinical biomarkers for immune checkpoint blockade

E Peranzoni, V Ingangi, E Masetto, L Pinton… - Frontiers in …, 2020 - frontiersin.org
Immune checkpoint inhibitors are becoming standard treatments in several cancer types,
profoundly changing the prognosis of a fraction of patients. Currently, many efforts are being …

[HTML][HTML] Baricitinib restrains the immune dysregulation in patients with severe COVID-19

V Bronte, S Ugel, E Tinazzi, A Vella… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Patients with coronavirus disease 2019 (COVID-19) develop pneumonia
generally associated with lymphopenia and a severe inflammatory response due to …

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells

S Solito, E Falisi, CM Diaz-Montero… - Blood, The Journal …, 2011 - ashpublications.org
We recently demonstrated that human BM cells can be treated in vitro with defined growth
factors to induce the rapid generation of myeloid-derived suppressor cells (MDSCs) …

[HTML][HTML] Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

R Trovato, A Fiore, S Sartori, S Canè, R Giugno… - … for immunotherapy of …, 2019 - Springer
Background Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with
an overall 5-year survival rate of less than 8%. New evidence indicates that PDAC cells …

[HTML][HTML] The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion

L Pinton, E Masetto, M Vettore, S Solito, S Magri… - … for immunotherapy of …, 2019 - Springer
Background Systemic and local immune suppression plays a significant role in glioma
progression. Glioma microenvironment contains both brain-resident microglial cells (MG) …

Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy

MS Sasso, G Lollo, M Pitorre, S Solito, L Pinton… - Biomaterials, 2016 - Elsevier
Tumor-induced expansion of myeloid-derived suppressor cells (MDSCs) is known to impair
the efficacy of cancer immunotherapy. Among pharmacological approaches for MDSC …

[HTML][HTML] Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression

L Pinton, S Solito, V Damuzzo, S Francescato… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The expansion of myeloid derived suppressor cells (MDSCs), a suppressive population able
to hamper the immune response against cancer, correlates with tumor progression and …

Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo

S Solito, L Pinton, F De Sanctis, S Ugel… - Current Protocols in …, 2019 - Wiley Online Library
This unit presents methods to assess the immunosuppressive properties of
immunoregulatory cells of myeloid origin, such as myeloid‐derived suppressor cells …